ProMIS Neurosciences Inc.
PMN | NASDAQ
$13.46
-$0.17 (-1.25%)
Sep 22, 2026, 11:56 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | 16.68K | 1.57K |
Cost of Revenue | 33.36M | n/a | 10.44M | n/a | 5.85M | 3.18M |
Gross Profit | -33.36M | n/a | -10.44M | n/a | -5.84M | -3.18M |
Operating Income | -40.17M | -16.83M | -18.9M | -23.38B | -10.57M | -5.66M |
Interest Income | n/a | n/a | n/a | n/a | 4.73K | n/a |
Pretax Income | -39.72M | 2.78M | -17.51M | -18.06B | -12.48M | -5.66M |
Net Income | -39.72M | 2.78M | -17.51M | -18.06B | -11.98M | -5.66M |
Selling & General & Admin | 6.79M | 6.19M | 6.38M | 7.29B | 3.31M | 2.48M |
Research & Development | 33.38M | 10.64M | 7.88M | 16.09B | 4.95M | 3.18M |
Other Expenses | n/a | n/a | -5.81M | n/a | -3.63M | -3.18M |
Operating Expenses | 40.17M | 16.83M | 8.45M | 23.38B | 4.63M | 2.48M |
Interest Expense | n/a | 76.78K | 201.39K | 282.06M | 416.29K | n/a |
Selling & Marketing Expenses | n/a | n/a | -1.01M | n/a | n/a | 36.48K |
Cost & Expenses | 40.17M | 16.83M | 18.9M | 23.38B | 10.86M | 5.66M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.76M | 1.04M | 491.71K | 300.1K | 231.42K | 190.4K |
Shares Outstanding (Diluted) | 1.76M | 1.06M | 491.71K | 300.1K | 231.43K | 190.4K |
EPS (Basic) | -22.61 | 2.75 | -35.50 | -60.25 | -51.77 | -29.74 |
EPS (Diluted) | -22.61 | 2.75 | -35.50 | -60.25 | -51.77 | -29.74 |
EBITDA | -39.72M | 2.86M | -17.81M | -17.78B | -9.33M | -5.65M |
EBIT | -39.72M | 2.86M | -17.84M | -17.78B | -9.37M | -5.66M |
Depreciation & Amortization | -724.69K | n/a | 28.04K | n/a | 45.83K | 15.73K |
Add to Watchlist
Select watchlists to add or remove PMN